The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): A study using a human RA/SCID mouse chimera

Rheumatology

Volumn 41, Issue 3, 2002, Pages 329-337

  Matsuno, H ^a,e   Yudoh, K ^a   Katayama, R ^a   Nakazawa, F ^a   Uzuki, M ^b   Sawai, T ^a   Yonezawa, T ^a   Saeki, Y ^c   Panayi, G S ^d   Pitzalis, C ^d   Kimura, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e NONE   (Japan)

Author keywords

Interleukin 6; Pathology; Rheumatoid arthritis; SCID mouse; Tumour necrosis factor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE INJURY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; JOINT DESTRUCTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SCID MOUSE; STIMULATION; SYNOVITIS; SYNOVIUM;

EID: 0036105564     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/41.3.329     Document Type: Article

References (30)

1. Cytokine blockade as a new strategy to treat rheumatoid arthritis: Inhibition of tumor necrosis factor
2. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor
3. Chronic exposure to tumor necrosis factor (TNF) in vitor impairs the activation of T cells through the T cell receptor/CD3 complex: Reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis
4. Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
5. NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy
6. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor a monoclonal antibody treatment in patients with rheumatoid arthritis
7. Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt?
8. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: Use of rheumatoid arthritis tissue implants in the SCID mouse model
9. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis
10. Apoptosis is a novel therapeutic strategy for RA: Investigations using an experimental arthritis animal model
11. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation
12. Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs. The disulfide structure fo SA-96 metabolites plays a critical role in the pharmacological action of the drug
13. Synovitis in rheumatoid arthritis: Scoring characteristic histopathological features
14. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: The role of telomerase activity in synovial proliferation
15. Reduced expression on the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis
16. Analysis of the histologic variation of synovitis in rheumatoid arthritis
17. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon γ
18. Effects of tumor necrosis factor-α, interleukin 1β, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice
19. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
20. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody
21. Tumor necrosis factor-alpha (TNF-α) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice
22. Synovial localizatioin of tumor necrosis factor in patients with rheumatoid arthritis
23. Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor a in the knee joints of patients with rheumatoid arthritis
24. The pathophysiology of tumor necrosis factors
25. The biology of interleukin-6
26. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
27. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
28. The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis
29. Effects of murine recombinant interleukin 1 on intact cartilage: A quantitative and autoradiographic study
30. Major role for interleukin 1 but not for tumour necrosis factor in early cartilage damage in immune complex arthritis in mice